RxDoctor Payments Data

Sara Cooke

Gerontology · Sebring, FLNPI 1174119820

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,634 of the $9,712 with a category attached, or 88.9%. It is spread thinly across 60 manufacturers, the largest accounting for just 9.2% — the pattern of someone who eats at a lot of different presentations. Among gerontology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,712in general payments, 2019–2025

Across 436 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$891
  • Johnson & Johnson$739
  • AstraZeneca$624
  • Lilly USA, LLC$613
  • Daiichi Sankyo Inc.$575
  • Seagen Inc.$458
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$8,63489%
  • Education$1,07811%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis54$891
Johnson & Johnson39$739
AstraZeneca(2 entities)31$624
Lilly USA, LLC20$613
Daiichi Sankyo Inc.23$575
Seagen Inc.18$458
Bayer21$408
Pfizer12$360
Sobi, Inc11$308
Incyte Corporation13$307
Takeda Pharmaceuticals U.S.A., Inc.12$303
Bristol Myers Squibb10$287
Eisai Inc.14$275
E.r. Squibb & Sons, L.L.C.16$273
Merck12$272
AbbVie7$237
Gilead9$215
Exelixis Inc.5$201
Deciphera Pharmaceuticals Inc.7$148
Stemline Therapeutics Inc.4$146
Astellas Pharma US Inc3$139
Array Biopharma Inc6$113
AVEO Pharmaceuticals, Inc.5$107
Dendreon Pharmaceuticals LLC5$97
Amgen6$96
Morphosys, US Inc.5$94
Genentech USA, Inc.5$91
Agios Pharmaceuticals, Inc.5$87
GSK4$83
Pharmaessentia USA Corporation3$77
Beigene USA, Inc.1$63
Tersera Therapeutics LLC3$59
Sumitomo Pharma America, Inc.3$51
Iovance Biotherapeutics, Inc.2$51
Syndax Pharmaceuticals, Inc.2$48
Ipsen Biopharmaceuticals, Inc2$48
Sanofi2$45
Pharmacosmos Therapeutics Inc.2$42
Karyopharm Therapeutics Inc.2$40
EMD Serono, Inc.2$38
Servier Pharmaceuticals LLC2$37
Sun Pharmaceutical Industries Inc.1$34
Apellis Pharmaceuticals, Inc.2$32
Genmab U.S., Inc.1$31
Ferring Pharmaceuticals Inc.2$29
Coherus Oncology, Inc.1$28
Adaptive Biotechnologies Corporation1$25
Rigel Pharmaceuticals, Inc.1$25
Helsinn Therapeutics (U.S.), Inc.1$25
Acrotech Biopharma Inc.1$24
Jazz Pharmaceuticals Inc.1$23
Boehringer Ingelheim1$22
Legend Biotech USA Inc.1$22
Recordati_rare_diseases_inc.1$21
Taiho Oncology, Inc.1$21
Menarini Silicon Biosystems, Inc.1$20
Springworks Therapeutics, Inc.1$19
G1 Therapeutics, Inc.1$19
Regeneron Healthcare Solutions, Inc.1$18
Urogen Pharma, Inc.1$17

How this compares

$9,712 in reported general payments places this provider in the 95th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$50,168
Letrozole80$2,194
Anastrozole78$1,376
Prochlorperazine Maleate25$906
Ondansetron OdtOndansetron19$858
Gabapentin20$361
Dexamethasone17$326
Hydroxyurea15$282
Acyclovir11$234
Pantoprazole Sodium14$150
Methylprednisolone16$98
Alendronate Sodium11$67
Trazodone Hcl14$66
Levofloxacin11$55

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$360$50,16846 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 714 gerontology providers in Florida.

Other gerontology in Sebring

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →